Stopped: Could not recruit participants due to their refusal to be randomized in the study.
Temporomandibular joint (TMJ) osteoarthritis (OA) affects articulating tissues secondary to inflammation resulting in intracapsular pain. This prospective, double-blind randomized clinical trial will evaluate the relative efficacy of TMJ arthrocentesis with a supplementation of platelet-rich growth factors (PRGF) compared to TMJ arthrocentesis with a steroid supplementation (a known effective therapy) for patients with TMJ OA.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Temporomandibular Joint (TMJ) Visual Analog Scale (VAS) Pain Rating
Timeframe: Three Months
Temporomandibular Joint (TMJ) Visual Analog Scale (VAS) Pain Rating
Timeframe: Six Months